1. Home
  2. EYE vs SNDX Comparison

EYE vs SNDX Comparison

Compare EYE & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYE
  • SNDX
  • Stock Information
  • Founded
  • EYE 1990
  • SNDX 2005
  • Country
  • EYE United States
  • SNDX United States
  • Employees
  • EYE N/A
  • SNDX N/A
  • Industry
  • EYE Ophthalmic Goods
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYE Health Care
  • SNDX Health Care
  • Exchange
  • EYE Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • EYE 900.5M
  • SNDX 974.9M
  • IPO Year
  • EYE 2017
  • SNDX 2016
  • Fundamental
  • Price
  • EYE $11.67
  • SNDX $11.54
  • Analyst Decision
  • EYE Hold
  • SNDX Strong Buy
  • Analyst Count
  • EYE 6
  • SNDX 10
  • Target Price
  • EYE $14.00
  • SNDX $36.20
  • AVG Volume (30 Days)
  • EYE 1.9M
  • SNDX 1.9M
  • Earning Date
  • EYE 05-07-2025
  • SNDX 05-07-2025
  • Dividend Yield
  • EYE N/A
  • SNDX N/A
  • EPS Growth
  • EYE N/A
  • SNDX N/A
  • EPS
  • EYE N/A
  • SNDX N/A
  • Revenue
  • EYE $1,823,320,000.00
  • SNDX $23,680,000.00
  • Revenue This Year
  • EYE $6.62
  • SNDX $286.51
  • Revenue Next Year
  • EYE $2.62
  • SNDX $120.86
  • P/E Ratio
  • EYE N/A
  • SNDX N/A
  • Revenue Growth
  • EYE 3.81
  • SNDX N/A
  • 52 Week Low
  • EYE $9.56
  • SNDX $9.66
  • 52 Week High
  • EYE $19.49
  • SNDX $25.07
  • Technical
  • Relative Strength Index (RSI)
  • EYE 46.31
  • SNDX 44.37
  • Support Level
  • EYE $11.29
  • SNDX $9.66
  • Resistance Level
  • EYE $12.00
  • SNDX $11.61
  • Average True Range (ATR)
  • EYE 0.81
  • SNDX 1.01
  • MACD
  • EYE -0.07
  • SNDX 0.02
  • Stochastic Oscillator
  • EYE 45.86
  • SNDX 56.12

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: